SynthesisBreast (Edinburgh, Scotland)2022

Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial-level Meta-analysis.

Neha Pathak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.